- Study found suicide attempters with schizophrenia showed higher epigenetic age acceleration on the Hannum DNAm Age clock than non-attempters.
- Other methylation clocks showed similar trends but differences lost significance after false discovery rate correction (pFDR = 0.2136).
- Findings suggest accelerated epigenetic ageing may associate with suicide risk in schizophrenia, warranting research into underlying mechanisms for prevention.
Schizophr Res. 2026 May 13;294:192-197. doi: 10.1016/j.schres.2026.04.020. Online ahead of print.
ABSTRACT
Suicide is a leading cause of death among individuals with schizophrenia. Studies suggest that suicide attempters show increased DNA methylation and shorter telomere lengths, both linked to accelerated biological aging. Recently, DNA methylation has been used to estimate epigenetic aging and telomere length, the former of which serves as the most accurate measure of biological aging. In this study, we investigated whether patients with schizophrenia spectrum disorder (SSD) and a history of suicide attempts show greater biological aging than non-attempters. Epigenetic aging and telomere length were assessed in DNA samples extracted from white blood cells of 60 SSD patients using methylation-based epigenetic clocks. Suicide attempters showed higher epigenetic age acceleration (EAA) on the Hannum DNAm Age clock compared to non-attempters, although other clocks displayed similar trends. However, this was no longer significant after correcting for multiple comparisons (p = 0.0356, pFDR = 0.2136). These findings suggest that accelerated epigenetic aging may be associated with suicide risk in schizophrenia. Finally, investigating the factors underlying this association would improve our understanding of suicidality and the ability to develop effective prevention measures.
PMID:42127842 | DOI:10.1016/j.schres.2026.04.020
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
